AI, Digital Therapeutics Transformation & Cross-Industry Collaboration – What’s On Tap at Frontiers Health

Frontiers Health global conference is just a few weeks away, and as founder and chairman of the event, it’s a special few days.  

Every year, Frontiers Health explores the most relevant health topics, leading the way for ecosystem collaboration that truly pushes the boundaries of what is possible.   

It’s more than a conference; it’s an annual gathering of a community committed to changing and improving global health.  Through the lenses of innovation and the ingenuity of forward-looking ideas that only happen at the frontiers, between the known and the unknown, the possible and the seemingly impossible, we nurture hopes for a better future. 

Of the many captivating topics that will be covered, here are the top three that resonate with me today and sessions featuring experts from EVERSANA on each.  

AI’s Transformative Impact   

The exponential growth of artificial intelligence and other emerging technologies is accelerating health transformation. Today, advances in AI enable us to improve diagnostics, personalize treatments through genomics, and monitor patient health in real time. Modern technologies, such as machine learning and big data, are transforming medicine in a preventive and predictive sense, allowing us to identify health risks in advance and intervene promptly in increasingly individualized ways. 

At Frontiers Health, we will highlight the transformative impact of AI in healthcare, focusing on its integration into regulated digital health solutions and its revolutionary role in drug discovery and commercialization, among other use cases. 

Sessions include: 

Transforming the pharma commercial model with AI [Deep Dive] 

• Scott Snyder – Chief Digital Officer, EVERSANA 

AI and Pricing and Market Access [Masterclass] 

• Alan Crowther – General Manager, Global Pricing & Access, EVERSANA 

Predictive ML model to select patients with diabetes and COPD needing continuous EKG monitoring to reduce clinical and economic disease burden: A Real-World Study. [Deep Dive] 

• Pierantonio Russo – Corporate Chief Medical Officer, EVERSANA 

Putting AI and Machine Learning Into Practice: Explore the Power to Drive Better Outcomes [Hands-on Workshop] 

• Abid Rahman – Senior Vice President, Innovation, EVERSANA 

Innovation in Digital Health and Value Creation 

Next-generation telemedicine is also enabling hybrid models that combine digital and physical experiences that offer increasingly customized solutions based on the specific needs of patients. This rapidly evolving environment is creating new opportunities for all stakeholders, including startups and technology companies, who can develop innovative products and services to meet current and future challenges in the healthcare system. 

This year, our content will spotlight groundbreaking innovations in digitally augmented therapies, digital-drug combos, digital health policies, and reimagining digital health collaborations. 

The Global Opportunity for Digital-Drug Combinations within Pharma [Masterclass] 

• Marty Culjat – SVP, Global Head of Digital Medicine & Regulatory Innovation, EVERSANA 

• Alberta Spreafico – SVP Health Innovation, EVERSANA 

Scaling Health Innovations Systemically: Bridging Policy and Practice – An Introduction to the Digital Health Policy Summit [Keynote] 

• Alberta Spreafico – SVP Health Innovation, EVERSANA 

Digital Health Policy Summit 2024 [Thematic Track] 

• Prof. Alberta Spreafico, SVP Health Innovation, EVERSANA; Adjunct Professor Policy & Economics, University of Pavia; Director Digital Health Policy Summit 

• Roberto Ascione, President, Health Innovation, EVERSANA; Chairman Frontiers Health   

• Marty Culjat, SVP, Global Head of Digital Medicine & Regulatory Innovation, EVERSANA 

Greater Business Impact, Script Lift and Brand Value: Next-Level Strategies for Customer Engagement [Deep Dive] 

• Justin Chase, Executive Vice President, EVERSANA INTOUCH Media 

• Dan Feldman, General Manager, Deployment Solutions, UK, Europe and APAC, EVERSANA 

 

Paving the way for Cross-industry Collaboration 

Concrete collaboration between investors, companies, universities, and institutions is crucial to promoting a culture of entrepreneurship and innovation. This synergy facilitates technology transfer and accelerates the innovation process, creating a fertile ecosystem for developing new business ideas and partnerships across the supply chain. Strong collaboration is also needed to accelerate regulatory paths necessary for validating the effectiveness of innovative solutions and their integration into health systems, ensuring adoption by doctors and patients. 

Frontiers Health offers a unique platform for discussion, bringing together a mix of participants from investment funds, life science companies, innovative hubs, health insurance companies, and startups. This convergence of innovations from different areas is transforming the health sector. 

Sessions include:  

Start-up and Scale-up Discovery 

• Paolo Borella, Vice President Health Innovation, EVERSANA 

Innovation Ecosystem Gathering [Thematic Track] 

• Kristin Milburn, SVP, Marketing Ecosystem & Strategy at EVERSANA, 

• Luigi Pavia, Ecosystem engagement & Partnerships at Frontiers Health 

• Paolo Borella – Vice President, Health Innovation, EVERSANA | Managing Partner & Head of Program, VITA Accelerator 

I personally cannot wait to see these sessions live and connect with these health innovators this October 17-18 in Berlin, Germany! Will you join us there? 

Register and save 20% by entering code FHEVS20 at www.frontiers.health.